Alembic Pharmaceuticals through its 100% owned subsidiary, Alembic Pharmaceuticals Inc., has completed acquisition of West Caldwell, New Jersey, USA based generic drug developer Orit Laboratories LLC (Orit) along with real estate, owned by Okner Realty LLC (Okner).
The acquisition increases Alembic’s US product portfolio with 7 approved ANDAs, and 4 ANDAs pending approval. The acquisition also increases Alembic’s breadth and capabilities in the US with a competent R&D team bringing complementary skill sets in soft-gelatin based oral solids and oral liquids.
Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907.
